Royal Bank of Canada’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.84M | Buy |
345,898
+345,685
| +162,293% | +$4.83M | ﹤0.01% | 2362 |
|
2025
Q1 | $3K | Sell |
213
-3,436
| -94% | -$48.4K | ﹤0.01% | 6147 |
|
2024
Q4 | $70K | Sell |
3,649
-2,772
| -43% | -$53.2K | ﹤0.01% | 5050 |
|
2024
Q3 | $146K | Buy |
6,421
+236
| +4% | +$5.37K | ﹤0.01% | 4628 |
|
2024
Q2 | $81K | Buy |
6,185
+4,399
| +246% | +$57.6K | ﹤0.01% | 5010 |
|
2024
Q1 | $32K | Sell |
1,786
-11,324
| -86% | -$203K | ﹤0.01% | 5276 |
|
2023
Q4 | $286K | Buy |
13,110
+7,242
| +123% | +$158K | ﹤0.01% | 4259 |
|
2023
Q3 | $90K | Buy |
5,868
+2,669
| +83% | +$40.9K | ﹤0.01% | 4969 |
|
2023
Q2 | $76K | Buy |
3,199
+1,049
| +49% | +$24.9K | ﹤0.01% | 5095 |
|
2023
Q1 | $54K | Sell |
2,150
-2,123
| -50% | -$53.3K | ﹤0.01% | 5206 |
|
2022
Q4 | $124K | Buy |
4,273
+3,950
| +1,223% | +$115K | ﹤0.01% | 4829 |
|
2022
Q3 | $7K | Buy |
323
+177
| +121% | +$3.84K | ﹤0.01% | 6126 |
|
2022
Q2 | $2K | Sell |
146
-6,791
| -98% | -$93K | ﹤0.01% | 6537 |
|
2022
Q1 | $128K | Buy |
+6,937
| New | +$128K | ﹤0.01% | 4996 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 6690 |
|
2020
Q3 | – | Sell |
-52
| Closed | -$1K | – | 6373 |
|
2020
Q2 | $1K | Hold |
52
| – | – | ﹤0.01% | 6010 |
|
2020
Q1 | $0 | Buy |
+52
| New | – | ﹤0.01% | 6343 |
|
2019
Q4 | – | Sell |
-2
| Closed | – | – | 6369 |
|
2019
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 6191 |
|
2018
Q4 | – | Sell |
-40
| Closed | -$3K | – | 6138 |
|
2018
Q3 | $3K | Buy |
40
+24
| +150% | +$1.8K | ﹤0.01% | 5834 |
|
2018
Q2 | $2K | Buy |
16
+9
| +129% | +$1.13K | ﹤0.01% | 5690 |
|
2018
Q1 | $1K | Hold |
7
| – | – | ﹤0.01% | 5618 |
|
2017
Q4 | $1K | Sell |
7
-66
| -90% | -$9.43K | ﹤0.01% | 5670 |
|
2017
Q3 | $10K | Buy |
73
+72
| +7,200% | +$9.86K | ﹤0.01% | 5516 |
|
2017
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5951 |
|